Role and implications of nanodiagnostics in the changing trends of clinical diagnosis

被引:43
作者
Alharbi, Khalid Khalaf [1 ]
Al-sheikh, Yazeed A. [1 ]
机构
[1] King Saud Univ, Coll Appl Med Sci, Dept Clin Lab Sci, Riyadh 11433, Saudi Arabia
关键词
Nanodiagnostics; PCR; DNA sequencing; MOLECULAR DIAGNOSTICS; IMMUNO-PCR; NANOPARTICLES; DNA; NANOTECHNOLOGY; TECHNOLOGY; SCAFFOLDS; DELIVERY;
D O I
10.1016/j.sjbs.2013.11.001
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Nanodiagnostics is the term used for the application of nanobiotechnology in molecular diagnosis, which is important for developing personalized cancer therapy. It is usually based on pharmacogenetics, pharmacogenomics, and pharmacoproteomic information but also takes into consideration environmental factors that influence response to therapy. Nanotechnology in medicine involves applications of nanoparticles currently under development, as well as longer range research that involves the use of manufactured nano-robots to make repairs at the cellular level. Nanodiagnostic technologies are also being used to refine the discovery of biomarkers, as nanoparticles offer advantages of high volume/surface ratio and multifunctionality. Biomarkers are important basic components of personalized medicine and are applicable to the management of cancer as well. The field of nano diagnostics raises certain ethical concerns related with the testing of blood. With advances in diagnostic technologies, doctors will be able to give patients complete health checks quickly and routinely. If any medication is required this will be tailored specifically to the individual based on their genetic makeup, thus preventing unwanted side-effects. (C) 2013 Production and hosting by Elsevier B.V. on behalf of King Saud University.
引用
收藏
页码:109 / 117
页数:9
相关论文
共 51 条
[1]   A real-time immuno-PCR assay for routine ultrasensitive quantification of proteins [J].
Adler, M ;
Wacker, R ;
Niemeyer, CM .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2003, 308 (02) :240-250
[2]  
Angeli E, 2008, TUMORI J, V94, P206
[3]  
[Anonymous], ACC CHEM RES
[4]   Nanodiagnostics: A new frontier for clinical laboratory medicine [J].
Azzazy, Hassan M. E. ;
Mansour, Mai M. H. ;
Kazmierczak, Steven C. .
CLINICAL CHEMISTRY, 2006, 52 (07) :1238-1246
[5]   Synthesis and antibacterial properties of silver nanoparticles [J].
Baker, C ;
Pradhan, A ;
Pakstis, L ;
Pochan, DJ ;
Shah, SI .
JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY, 2005, 5 (02) :244-249
[6]   SNP identification in unamplified human genomic DNA with gold nanoparticle probes [J].
Bao, YP ;
Huber, M ;
Wei, TF ;
Marla, SS ;
Storhoff, JJ ;
Muller, UR .
NUCLEIC ACIDS RESEARCH, 2005, 33 (02) :e15
[7]   Lowering the detection limits of HIV-1 viral load using real-time Immuno-PCR for HIV-1 p24 antigen [J].
Barletta, JM ;
Edelman, DC ;
Constantine, NT .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2004, 122 (01) :20-27
[8]   Nanofiber technology: Designing the next generation of tissue engineering scaffolds [J].
Barnes, Catherine P. ;
Sell, Scott A. ;
Boland, Eugene D. ;
Simpson, David G. ;
Bowlin, Gary L. .
ADVANCED DRUG DELIVERY REVIEWS, 2007, 59 (14) :1413-1433
[9]  
Burns M., 1998, SCIENCE, V282, P15
[10]   Recommendations of the National Heart, Lung, and Blood Institute Nanotechnology Working Group [J].
Buxton, DB ;
Lee, SC ;
Wickline, SA ;
Ferrari, M .
CIRCULATION, 2003, 108 (22) :2737-2742